Global burden
Why diabetic foot is a strategic imperative—not a niche complication
Across health systems worldwide, diabetes-related foot disease concentrates morbidity, cost, and preventable limb loss in a single, inspectable anatomical corridor—the foot—yet workflows often fragment between primary care, podiatry, vascular surgery, wound centers, and hospitals.
Adults living with diabetes globally (International Diabetes Federation Diabetes Atlas, 2021 estimate).
Lifetime prevalence of diabetic foot ulcer is frequently summarized near one in four people with diabetes in global syntheses—exact ratios vary by cohort, geography, and screening intensity.
Diabetes is among the dominant contributors to non-traumatic lower-extremity amputation—often preceded by neuropathy, deformity, repetitive trauma, or infection.
Figures summarize widely cited epidemiology and guideline summaries (for example IDF Atlas editions and diabetic-foot consensus literature); regional audits may differ.
The arithmetic is unforgiving at population scale: peripheral neuropathy reduces protective sensation; peripheral arterial disease limits perfusion; minor trauma escalates through delayed detection, infection, and tissue loss. Hospital episodes stretch capacity; healing cycles consume nursing time; major amputation correlates with profound downstream mortality and dependence.
Structured assessment at the point of care is the lever clinicians still control. International diabetic-foot frameworks emphasize risk stratification, urgency-aware escalation, multidisciplinary coordination, and documentation that survives referral—not ad hoc descriptions trapped in unstructured notes.
Digital clinical decision support aligned to those frameworks is therefore need-of-the-hour infrastructure, not optional tooling for “later optimization.” The gap between guideline intent and everyday execution is where preventable admissions—and preventable losses—accumulate.
PairXCare exists to shrink that gap without replacing judgment: consistent SINBAD-aligned capture, clearer communication artifacts between visits and teams, and reporting that reinforces accountable follow-through—while keeping therapeutic decisions with licensed professionals and local policy.